Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

IPI-926 is well tolerated and active in patients with solid tumors

Oct. 15, 2010

ESMO and Thomson Reuters collaborate on oncology web portal

Oct. 14, 2010

Genentech begins phase II vismodegib trial in operable basal cell carcinoma

Oct. 14, 2010

Tesetaxel receives EMA orphan drug status for gastric cancer

Oct. 14, 2010

Boehringer Ingelheim discloses new FADK 1 inhibitors

Oct. 14, 2010

Helix BioPharma completes GLP toxicology studies of L-DOS-47

Oct. 14, 2010

Seattle Genetics reports phase II data on brentuximab vedotin in lymphoma

Oct. 13, 2010

ArQule and Daiichi Sankyo agree with FDA on SPA for phase III ARQ-197 trial

Oct. 13, 2010

Researchers synthesize new oncolytic gold complexes

Oct. 13, 2010

State University of New York, Albany claims novel antiestrogens

Oct. 13, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...